Development of a novel therapeutic strategy for treatment of SOD1-linked ALS by CRISPR/Cas9-mediated SOD1 promoter editing

Project: Research project

Project Details

StatusFinished
Effective start/end date7/1/206/30/24

Funding

  • National Institute of Neurological Disorders and Stroke (5R01NS118928-03)